Lendio, Yulie S.
HRN: 26-51-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/11/2025
01/18/2025
IV
4.5g
Q8h
Cellulitis, L Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes